Purpose
Compliant version of the Adult Immunization Schedule by Age
Ages 19 Years or Older
< < Back to Adult Immunization Schedule by Age Group
¶ = Recommended vaccination for adults who meet age requirement, lack documentation of vaccination, or lack evidence of immunity
§ = Recommended vaccination for adults with an additional risk factor or another indication
± = Recommended vaccination based on shared clinical decision-making
⇒ = No Guidance/Not Applicable
| Vaccine | 19-26 years | 27-49 years | 50-64 years | ≥65 years | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COVID-19  |
1 or more doses of 2024–2025 vaccine (See Notes)¶ | 2 or more doses of 2024-2025 vaccine (See Notes)¶ |
||||||||||||
| Influenza inactivated (IIV3, ccIIV3) Influenza recombinant (RIV3) |
1 dose annually¶ | 1 dose annually (HD–IIV3, RIV3, or aIIV3 preferred)¶ |
||||||||||||
| Influenza inactivated (aIIV3; HD–IIV3) Influenza recombinant (RIV3) |
Solid organ transplant (See Notes)§ | |||||||||||||
| Influenza live, attenuated (LAIV3) |
1 dose annually¶ | ⇒ | ||||||||||||
| Respiratory Syncytial Virus (RSV) |
Seasonal administration during pregnancy.
(See Notes)§ |
⇒ |
|
≥75 years¶ | ||||||||||
| Tetanus, diphtheria, pertussis (Tdap or Td) |
1 dose Tdap each pregnancy; 1 dose Td/Tdap for wound management (See Notes)§ | |||||||||||||
| 1 dose Tdap, then Td or Tdap booster every 10 years¶ | ||||||||||||||
| Measles, mumps, rubella (MMR) |
1 or 2 doses depending on indication (if born in 1957 or later)¶ |
|
||||||||||||
| Varicella (VAR) |
|
2 doses | ||||||||||||
| Zoster recombinant (RZV) |
2 doses for immunocompromising conditions (See Notes)§ |
2 doses¶ | ||||||||||||
| Human papillomavirus (HPV) |
2 or 3 doses depending on age at initial vaccination or condition¶ | 27 through 45 years± | ⇒ | |||||||||||
| Pneumococcal (PCV15, PCV20,PCV21, PPSV23) |
§ | ¶ | See Notes¶ | |||||||||||
| See Notes± | ||||||||||||||
| Hepatitis A (HepA) |
2, 3, or 4 doses depending on vaccine§ | |||||||||||||
| Hepatitis B (HepB) |
|
|||||||||||||
| Meningococcal A, C, W, Y (MenACWY) |
1 or 2 doses depending on indication (See notes for booster recommendations)§ | |||||||||||||
| Meningococcal B (MenB) |
2 or 3 doses depending on vaccine and indication (See notes for booster recommendations)§ | |||||||||||||
| 19 through 23 years± | § | |||||||||||||
| Haemophilus influenzae type b (Hib) |
1 or 3 doses depending on indication§ | |||||||||||||
| Mpox |
2 doses§ | |||||||||||||
| Inactivated poliovirus (IPV) |
Complete 3-dose series if incompletely vaccinated. Self–report of previous doses acceptable (See Notes)¶ | |||||||||||||
Content Source:
National Center for Immunization and Respiratory Diseases